Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria

  • de la Cuesta, Fernando
  • Baldan-Martin, Montserrat
  • Moreno-Luna, Rafael
  • Alvarez-Llamas, Gloria
  • Gonzalez-Calero, Laura
  • Mourino-Alvarez, Laura
  • Sastre-Oliva, Tamara
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Ruiz-Hurtado, Gema
  • Segura, Julian
  • Vivanco, Fernando
  • Ruilope, Luis M
  • Barderas, Maria G
Despite of the great advances in anti-hypertensive therapies, many patients under Renin-Angiotensin-System (RAS) suppression develop albuminuria, which is a clear indicator of therapeutic inefficiency. Hence, indicators of vascular function are needed to assess patients' condition and help deciding future therapies. Proteomic analysis of circulating extracellular vesicles (EVs) showed two proteins, kalirin and chromodomain-helicase-DNA-binding protein 7 (CHD7), increased in albuminuric patients. A positive correlation of both with the expression of the endothelial activation marker E-selectin was found in EVs. In vitro analysis using TNFa-treated adult human endothelial cells proved their involvement in endothelial cell activation. Hence, we propose protein levels of kalirin and CHD7 in circulating EVs as novel endothelial dysfunction markers to monitor vascular condition in hypertensive patients with albuminuria.
Repisalud
Publication Artículo científico (JournalArticle)

Plasma Molecular Signatures in Hypertensive Patients With Renin-Angiotensin System Suppression: New Predictors of Renal Damage and De Novo Albuminuria Indicators

  • Baldan-Martin, Montserrat
  • Mourino-Alvarez, Laura
  • Gonzalez-Calero, Laura
  • Moreno-Luna, Rafael
  • Sastre-Oliva, Tamara
  • Ruiz-Hurtado, Gema
  • Segura, Julian
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Vivanco, Fernando
  • Alvarez-Llamas, Gloria
  • Ruilope, Luis M
  • de la Cuesta, Fernando
  • Barderas, Maria G
Albuminuria is a risk factor strongly associated with cardiovascular disease, the first cause of death in the general population. It is well established that renin-angiotensin system suppressors prevent the development of new-onset albuminuria in naïf hypertensive patients and diminish its excretion, but we cannot forget the percentage of hypertensive patients who develop de novo albuminuria. Here, we applied multiple proteomic strategy with the purpose to elucidate specific molecular pathways involved in the pathogenesis and provide predictors and chronic organ damage indicators. Briefly, 1143 patients were followed up for a minimum period of 3 years. One hundred and twenty-nine hypertensive patients chronically renin-angiotensin system suppressed were recruited, classified in 3 different groups depending on their albuminuria levels (normoalbuminuria, de novo albuminuria, and sustained albuminuria), and investigated by multiple proteomic strategies. Our strategy allowed us to perform one of the deepest plasma proteomic analysis to date, which has shown 2 proteomic signatures: (1) with predictive value of de novo albuminuria and (2) sustained albuminuria indicator proteins. These proteins are involved in inflammation, immune as well as in the proteasome activation occurring in situations of endoplasmic reticulum stress. Furthermore, these results open the possibility of a future strategy based on anti-immune therapy to treat hypertension which could help to prevent the development of albuminuria and, hence, the progression of kidney damage.
Repisalud
Publication Artículo científico (JournalArticle)

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria

  • Martin-Lorenzo, Marta
  • Gonzalez-Calero, Laura
  • Martinez, Paula J.
  • Baldan-Martin, Montserrat
  • Lopez, Juan Antonio
  • Ruiz-Hurtado, Gema
  • de la Cuesta, Fernando
  • Segura, Julian
  • Vazquez, Jesus
  • Vivanco, Fernando
  • Barderas, Maria G
  • Ruilope, Luis M
  • Alvarez-Llamas, Gloria
Albuminuria development in hypertensive patients is an indicator of higher cardiovascular (CV) risk and renal damage. Chronic renin-angiotensin system (RAS) suppression facilitates blood pressure control but it does not prevent from albuminuria development. We pursued the identification of protein indicators in urine behind albuminuria development in hypertensive patients under RAS suppression. Urine was collected from 100 patients classified in three groups according to albuminuria development: (a) patients with persistent normoalbuminuria; (b) patients developing de novo albuminuria; (c) patients with maintained albuminuria. Quantitative analysis was performed in a first discovery cohort by isobaric labeling methodology. Alterations of proteins of interest were confirmed by target mass spectrometry analysis in an independent cohort. A total of 2416 proteins and 1223 functional categories (coordinated protein responses) were identified. Immune response, adhesion of immune and blood cells, and phagocytosis were found significantly altered in patients with albuminuria compared to normoalbuminuric individuals. The complement system C3 increases, while Annexin A1, CD44, S100A8 and S100A9 proteins showed significant diminishment in their urinary levels when albuminuria is present. This study reveals specific links between immune response and controlled hypertension in patients who develop albuminuria, pointing to potential protein targets for novel and future therapeutic interventions.
Repisalud
Publication Artículo científico (JournalArticle)

Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria

  • Gonzalez-Calero, Laura
  • Martinez, Paula J.
  • Martin-Lorenzo, Marta
  • Baldan-Martin, Montserrat
  • Ruiz-Hurtado, Gema
  • de la Cuesta, Fernando
  • Calvo, Eva
  • Segura, Julian
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Barderas, Maria G
  • Ruilope, Luis M
  • Vivanco, Fernando
  • Alvarez-Llamas, Gloria
Albuminuria is an indicator of cardiovascular risk and renal damage in hypertensive individuals. Chronic renin-angiotensin system (RAS) suppression facilitates blood pressure control and prevents development of new-onset-albuminuria. A significant number of patients, however, develop albuminuria despite chronic RAS blockade, and the physiopathological mechanisms are underexplored. Urinary exosomes reflect pathological changes taking place in the kidney. The objective of this work was to examine exosomal protein alterations in hypertensive patients with albuminuria in the presence of chronic RAS suppression, to find novel clues underlying its development. Patients were followed-up for three years and were classified as: a) patients with persistent normoalbuminuria; b) patients developing de novo albuminuria; and c) patients with maintained albuminuria. Exosomal protein alterations between groups were identified by isobaric tag quantitation (iTRAQ). Confirmation was approached by target analysis (SRM). In total, 487 proteins were identified with high confidence. Specifically, 48 proteins showed an altered pattern in response to hypertension and/or albuminuria. Out of them, 21 proteins interact together in three main functional clusters: glycosaminoglycan degradation, coagulation and complement system, and oxidative stress. The identified proteins constitute potential targets for drug development and may help to define therapeutic strategies to evade albuminuria progression in hypertensive patients chronically treated.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

  • Martinez-Cengotitabengoa, M.
  • Macdowell, K.S.
  • Alberich, S.
  • Diaz, F.J.
  • Garcia-Bueno, B.
  • Rodriguez-Jimenez, R.
  • Bioque, M.
  • Berrocoso, E.
  • Parellada, M.
  • Lobo, A.
  • Saiz, P.A.
  • Matute, C.
  • Bernardo, M.
  • Gonzalez-Pinto, A.
  • Leza, J.C.
Previous studies have indicated systemic deregulation of the proinflammatory or anti-inflammatory balance in individuals with first-episode psychosis (FEP) that persists 12 months later. To identify potential risk/protective factors and associations with symptom severity, we assessed possible changes in plasma levels of neurotrophins (brain-derived neurotrophic factor BDNF] and nerve growth factor NGF]) and their receptors in peripheral blood mononuclear cells (PBMCs). Expression of the 2 forms of BDNF receptors (active TrkB-FL and inactiveTrkB-T1) in PBMCs of FEP patients changed over time, TrkB-FL expression increasing by 1 year after diagnosis, while TrkB-T1 expression decreased. The TrkB-FL/TrkB-T1 ratio (hereafter FL/T1 ratio) increased during follow-up in the nonaffective psychosis group only, suggesting different underlying pathophysiological mechanisms in subgroups of FEP patients. Further, the expression of the main NGF receptor, TrkA, generally increased in patients at follow-up. After adjusting for potential confounders, baseline levels of inducible isoforms of nitric oxide synthase, cyclooxygenase, and nuclear transcription factor were significantly associated with the FL/T1 ratio, suggesting that more inflammation is associated with higher values of this ratio. Interestingly, the FL/T1 ratio might have a role as a predictor of functioning, a regression model of functioning at 1 year suggesting that the effect of the FL/T1 ratio at baseline on functioning at 1 year depended on whether patients were treated with antipsychotics. These findings may have translational relevance; specifically, it might be useful to assess the expression of TrkB receptor isoforms before initiating antipsychotic treatment in FEPs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History

  • González-Pinto, Ana|||0000-0002-2568-5179
  • González-Ortega, Itxaso|||0000-0001-7074-4353
  • Alberich, Susana|||0000-0002-4945-3428
  • Ruiz de Azúa, Sonia
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Bioque, Miquel|||0000-0001-6887-7149
  • Cabrera, Bibiana|||0000-0002-7749-5449
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Arango, Celso|||0000-0003-3382-4754
  • Lobo, Antonio|||0000-0002-9098-655X
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Cuesta, Manuel J.|||0000-0003-0250-5718
The objective of this study is to investigate cognitive performance in a first-episode psychosis sample, when stratifying the interaction by cannabis use and familial or non-familial psychosis. Hierarchical-regression models were used to analyse this association in a sample of 268 first-episode psychosis patients and 237 controls. We found that cannabis use was associated with worse working memory, regardless of family history. However, cannabis use was clearly associated with worse cognitive performance in patients with no family history of psychosis, in cognitive domains including verbal memory, executive function and global cognitive index, whereas cannabis users with a family history of psychosis performed better in these domains. The main finding of the study is that there is an interaction between cannabis use and a family history of psychosis in the areas of verbal memory, executive function and global cognition: that is, cannabis use is associated with a better performance in patients with a family history of psychosis and a worse performance in those with no family history of psychosis. In order to confirm this hypothesis, future research should explore the actual expression of the endocannabinoid system in patients with and without a family history of psychosis.